Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.

Carleton NM, Zhu G, Gorbounov M, Miller MC, Pienta KJ, Resar LMS, Veltri RW.

Prostate. 2018 May;78(7):547-559. doi: 10.1002/pros.23499. Epub 2018 Mar 9.

PMID:
29520928
2.

HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.

Xian L, Georgess D, Huso T, Cope L, Belton A, Chang YT, Kuang W, Gu Q, Zhang X, Senger S, Fasano A, Huso DL, Ewald AJ, Resar LMS.

Nat Commun. 2017 Apr 28;8:15008. doi: 10.1038/ncomms15008.

3.

Hmga1 deficiency: "SAC-King" the SAC genes to incite chromosomal instability.

Xian L, Reddy KA, Resar LM.

Cell Cycle. 2017 Jan 2;16(1):17-18. doi: 10.1080/15384101.2016.1214034. Epub 2016 Dec 15. No abstract available.

4.

Bloodless medicine: current strategies and emerging treatment paradigms.

Resar LM, Wick EC, Almasri TN, Dackiw EA, Ness PM, Frank SM.

Transfusion. 2016 Oct;56(10):2637-2647. doi: 10.1111/trf.13736. Epub 2016 Jul 29. Review.

PMID:
27473810
5.

Patent foramen ovale in adults with sickle cell disease and stroke.

Razdan S, Strouse JJ, Reddy A, Resar DF, Hasan RK, Resar JR, Naik RP, Urrutia VC, Lanzkron S, Resar LM.

Am J Hematol. 2016 Sep;91(9):E358-60. doi: 10.1002/ajh.24440. Epub 2016 Jul 20. No abstract available.

6.

The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.

Hillion J, Roy S, Heydarian M, Cope L, Xian L, Koo M, Luo LZ, Kellyn K, Ronnett BM, Huso T, Armstrong D, Reddy K, Huso DL, Resar LMS.

Gynecol Oncol. 2016 Jun;141(3):580-587. doi: 10.1016/j.ygyno.2016.03.020. Epub 2016 Apr 8.

7.

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Sumter TF, Xian L, Huso T, Koo M, Chang YT, Almasri TN, Chia L, Inglis C, Reid D, Resar LM.

Curr Mol Med. 2016;16(4):353-93. Review.

8.

Ultramassive transfusion: give blood, save a life.

Frank SM, Johnson DJ, Resar LM.

Transfusion. 2016 Mar;56(3):546-8. doi: 10.1111/trf.13403. No abstract available.

PMID:
26954450
9.

STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.

Belton A, Xian L, Huso T, Koo M, Luo LZ, Turkson J, Page BD, Gunning PT, Liu G, Huso DL, Resar LM.

Leuk Lymphoma. 2016 Nov;57(11):2681-4. doi: 10.3109/10428194.2016.1153089. Epub 2016 Mar 8. No abstract available.

10.

The Efficacy and Utility of Acute Normovolemic Hemodilution.

Grant MC, Resar LM, Frank SM.

Anesth Analg. 2015 Dec;121(6):1412-4. doi: 10.1213/ANE.0000000000000935. No abstract available.

PMID:
26579641
11.

Hemoglobin thresholds for transfusion in pediatric patients at a large academic health center.

Klaus SA, Frank SM, Salazar JH, Cooper S, Beard L, Abdullah F, Fackler JC, Heitmiller ES, Ness PM, Resar LM.

Transfusion. 2015 Dec;55(12):2890-7. doi: 10.1111/trf.13296. Epub 2015 Sep 29.

PMID:
26415860
12.

Through a Gender Lens: A View of Gender and Leadership Positions in a Department of Medicine.

Monroe AK, Levine RB, Clark JM, Bickel J, MacDonald SM, Resar LM.

J Womens Health (Larchmt). 2015 Oct;24(10):837-42. doi: 10.1089/jwh.2014.5054. Epub 2015 Jul 22.

PMID:
26200812
13.

Characterizing metabolic changes in human colorectal cancer.

Williams MD, Zhang X, Park JJ, Siems WF, Gang DR, Resar LM, Reeves R, Hill HH Jr.

Anal Bioanal Chem. 2015 Jun;407(16):4581-95. doi: 10.1007/s00216-015-8662-x. Epub 2015 May 6.

PMID:
25943258
14.

How I treat priapism.

Anele UA, Le BV, Resar LM, Burnett AL.

Blood. 2015 Jun 4;125(23):3551-8. doi: 10.1182/blood-2014-09-551887. Epub 2015 Mar 25.

15.

IBRUTinib: BRUTe force against bortezomib-resistant myeloma cells.

Xian L, Huff CA, Resar LM.

Cell Cycle. 2015;14(9):1349-50. doi: 10.1080/15384101.2015.1022058. No abstract available.

16.

Bloodless medicine: what to do when you can't transfuse.

Resar LM, Frank SM.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):553-8. doi: 10.1182/asheducation-2014.1.553. Epub 2014 Nov 18. Review.

PMID:
25696910
17.

Efficacy of education followed by computerized provider order entry with clinician decision support to reduce red blood cell utilization.

Zuckerberg GS, Scott AV, Wasey JO, Wick EC, Pawlik TM, Ness PM, Patel ND, Resar LM, Frank SM.

Transfusion. 2015 Jul;55(7):1628-36. doi: 10.1111/trf.13003. Epub 2015 Feb 3.

PMID:
25646579
18.

HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis.

Williams MD, Zhang X, Belton AS, Xian L, Huso T, Park JJ, Siems WF, Gang DR, Resar LM, Reeves R, Hill HH Jr.

J Proteome Res. 2015 Mar 6;14(3):1420-31. doi: 10.1021/pr501084s. Epub 2015 Feb 23.

PMID:
25643065
19.

Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.

All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou BK, Shah S, Resar LM, Cheng L, Gearhart JD, Kerr CL.

PLoS One. 2015 Jan 30;10(1):e0116933. doi: 10.1371/journal.pone.0116933. eCollection 2015.

20.

Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Frank SM, Wick EC, Dezern AE, Ness PM, Wasey JO, Pippa AC, Dackiw E, Resar LM.

Transfusion. 2014 Oct;54(10 Pt 2):2668-77. doi: 10.1111/trf.12752. Epub 2014 Jun 18.

Supplemental Content

Loading ...
Support Center